Plaintiff in Stryker Hip Lawsuit Files Motion to Consolidate Cases in Minnesota Federal Court
A motion to consolidate all Stryker hip recall lawsuits in Minnesota federal court has been filed by a plaintiff who allegedly suffered complications from the Stryker Rejuvenate modular-neck hip stem.
The request to centralize pretrial proceedings of claims filed over devices affected by July 2012’s Stryker hip recall was filed Feb. 19, 2013 with the U.S. Judicial Panel on Multidistrict Litigation (JPML). According to court documents, at least 30 Stryker Rejuvenate and ABG II hip lawsuits are pending in federal courts around the U.S. right now, and dispersed among 12 different U.S. District Courts.
This number may be likely to rise in the coming months since thousands of Rejuvenate implants were sold throughout the U.S. prior to last summer’s Stryker hip recall.
Motion to Transfer Stryker Hip Lawsuits Filed in February
In his request to consolidate these lawsuits in the U.S. District Court for the District of Minnesota, the plaintiff noted that at least 10 of the above claims are pending there. Centralizing these claims will also reduce duplicative discovery in a large number of similar claims, serve the convenience of the parties and avoid conflicting rulings from judges.
The Stryker hip recall was voluntarily issued by Stryker Orthopaedics on July 6, 2012 after post-market surveillance data indicated the modular-neck hip stems’ potential to fret and corrode at the modular-neck junction, which could lead to adverse tissue reactions, metallosis (metal ion poisoning), pain and swelling and other Stryker hip problems.
At the time of the Stryker hip recall, the company released the following statement: “While modular neck hip stems provide surgeons with an option to correct certain aspects of a patient’s anatomy and hip biomechanics, we decided to voluntarily recall these modular-neck stem hip systems because there is a potential for fretting and corrosion at the modular neck junction which may lead to adverse local tissue reactions.
During 2012 alone, the U.S. Food and Drug Administration (FDA) reportedly received at least 45 adverse event reports from patients who received the Stryker Rejuvenate and/or ABG II modular-neck hip stems.
Considering a Lawsuit Following the Stryker Hip Recall? Call Us Today.
If you suffered pain and swelling, metallosis and/or early failure rates after receiving the Stryker Rejuvenate and/or ABG II hip implants, you may be eligible for compensation for your injuries. Call an attorney at Bernstein Liebhard LLP at (877) 779-1414.